Tag: Jeffrey Lieberman

When the neuroleptics-are-necessary-to-treat-schizophrenia myth falls, psychiatry is finished. And that is why the Goff et al paper was produced: a desperate attempt to maintain its position by a profession that is truly on the ropes. For psychiatry this is a death-struggle.

Jeffrey LIeberman and colleagues have published a paper in the American Journal of Psychiatry stating that there is no evidence that psychiatric drugs cause long-term harm, and that the evidence shows that these drugs provide a great benefit to patients. A close examination of their review reveals that it is a classic example of institutional corruption, which was meant to protect guild interests.

A career update for members of the “Psychiatry Hall of Shame,” including the group excoriated in the 2008 Congressional investigations, and another psychiatrist who conducted studies aimed at inducing psychosis—experiments that appeared to run counter to the Nuremberg Code of research ethics.

There is indeed a crisis in the mental health business. The crisis derives from psychiatry's spurious and self-serving premise that all significant problems of thinking, feeling, and/or behaving are brain illnesses that are correctable by psychiatric drugs.

Organized psychiatry, committed irrevocably and wholeheartedly to drug pushing and to their corrupt and corrupting relationship with pharma, simply will not countenance the fact that their primary product is fundamentally flawed and destructive. So they hire a PR company; they fund and lobby politicians; they parrot slogans; and they encourage one another to ever-increasing heights of self-congratulation. But they will not commission a definitive study to clarify and assess the scale of this problem once and for all. And the reason for this inaction is because they know that it would be bad for business. It would "cause a lot of people to stop taking their medications."

Speaking to Medscape about PTSD, Jeffrey Lieberman likens our current treatments with SSRIs, tricyclics and therapy to "treating tuberculous by putting people in sanitariums or polio with iron lungs, or Alzheimer's disease with these cholinomimetic drugs.” "They are symptom-improving, but they're not disease-modifying,” he adds. “They're just not sufficient…”

I imagine that everybody on this side of the issue knows by now that the eminent psychiatrist Jeffrey Lieberman, MD, Chief Psychiatrist at Columbia, and past President of the APA, called Robert Whitaker "a menace to society." The grounds for Dr. Lieberman's vituperation were that Robert had dared to challenge some of psychiatry's most sacred tenets! But in all the furor, it was largely ignored that in the same interview Dr. Lieberman had said something else that warrants additional discussion.